What’s New in Immune Cell Therapy Research?
Since 2011, immunotherapy has emerged as an exciting new approach to cancer treatment that is yielding unprecedented, durable responses...
Category: Meetings
Since 2011, immunotherapy has emerged as an exciting new approach to cancer treatment that is yielding unprecedented, durable responses...
Decades of research have led to the identification of an increasing number of cancer-causing substances in our environment. These...
The Fifth AACR New Horizons in Cancer Research (NHiCR) international conference has concluded, and the more than 400 attendees...
Shenzhen is a remarkable place. It serves as a gateway to Hong Kong, and in its short 40-year history...
Greetings from Shenzhen, China, where the Fifth AACR New Horizons in Cancer Research (NHiCR) Conference is now underway. The event’s...
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
One of the world’s largest cancer research conferences, the AACR Annual Meeting 2019, came to an end with a...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
Although checkpoint inhibitors and other immunotherapies are remarkably effective for patients with some cancers, demonstrating durable antitumor activity and/or...